|
|
|
|
|
|
By BioPhorum | Gene therapy manufacturing produces low volumes, which makes giving up product for testing a dispiriting task. Save product during bioburden and sterility testing with these strategies. |
|
|
|
By Matthew Pillar, Editor, Bioprocess Online
| By modifying CD4 T cells using miRNA, Jeff Galvin’s company thinks it can deliver a functional cure for HIV. Here’s the ongoing story of Addimmune and its unique clinical strategy. |
|
|
|
| Standardization And Flexibility In Aseptic Filling | Article | Cytiva | Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose? |
|
|
|
| Adopting Modular Approaches To Optimize CGT Development | Article | By Rubina Pal and Alicia Kramer, Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | There are several technology solutions that, when applied to a cell and gene therapy workflow, can streamline development and improve workflow integration. |
|
|
| Developability Assessment Of Three Therapeutic Antibodies | Poster | By Tao Bi, Yesenia Aguilar, Paul Phelan, Laura McDevitt, Henry Yong, David Gae, Anjali Patel, Wen-Rong Jiang, Tao He, and Zhiping Yao, JOINN Biologics | This poster reviews studies for three monoclonal antibody drug candidates utilizing a panel of small scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability. |
|
|
|
| How Scale-Up Benefits A Clinical Program To Get Results | Article | By M. Omon Herigstad, Evan Pasenello, Mark A. Shannon, Paul M. Reynolds, and Andrew S. Bulger, AbbVie | A scalable manufacture promises increased process understanding and manufacturing flexibility to deliver a robust, reliable commercial product, and it helps with timely delivery to market. |
|
|
|
| Understanding The Oligonucleotide Synthesis Process | Video | Cytiva | Synthetic oligonucleotides are primarily used in therapeutics, as well as in diagnostic kits and PCR primers. This animation explains the repetitive four-step cycle of the oligonucleotide synthesis process. |
|
|
|
|
| Scale-Up Evaluation DynaDrive S.U.B.s | Application Note | By Jordan Cobia and Ben Madsen, Thermo Fisher Scientific Bioproduction | Recently developed process intensification has allowed for increased product output. This output requires increased production efficiency and input, pushing many bioreactor systems past their limits. |
|
|
|
|
| Innovations In ADC Technologies | Webinar | Catalent | Examine the drivers behind the recent successes in the clinic, current challenges with development and manufacturing, and what the future might hold for the ADC industry. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|